Skip to main content
Year archive

Tego Science, Inc. — 2023 filings

All 17 regulatory filings released by Tego Science, Inc. (191420) in 2023, sourced directly from the official regulator.

17 Filings
2023 Period
2023 filings (17)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2023-12-15 Korean
투자판단관련주요경영사항(임상시험결과)(로스미르(TPX-105) 국내 임상시험 제3상 결과)
Regulatory Filings
2023-11-14 Korean
분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-14 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-09-01 Korean
반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-08-14 Korean
투자판단관련주요경영사항(임상시험계획승인신청)(코입술주름 개선을 위한 세포치료제 TPX-121의 국내 제1상 임상시험계획(IND) 신청)
Regulatory Filings
2023-07-13 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Q1 2023
2023-05-15 Korean
투자판단관련주요경영사항(임상시험계획승인신청등결정)(회전근개파열 세포치료제 TPX-115 제 2b/3상 임상시험계획 승인)
Legal Proceedings Report
2023-05-09 Korean
투자판단관련주요경영사항(회전근개 전층 파열 세포치료제 TPX-114 국내 제1/3상 임상시험 결과)
Legal Proceedings Report
2023-04-28 Korean
기업설명회(IR)개최
Report Publication Announcement
2023-04-04 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-03-30 Korean
사업보고서 (2022.12)
Annual Report FY 2022
2023-03-23 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-03-22 Korean
주주총회소집공고
AGM Information
2023-03-15 Korean
주주총회소집결의
AGM Information
2023-03-13 Korean
주주총회집중일개최사유신고
AGM Information
2023-03-13 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2022
2023-02-09 Korean